Clinical Trial Search

Primary: Percentage of Leukocyte Subsets Including B Lymphocytes, Classical B Lymphocytes, Double Negative B Lymphocytes, Naive B Lymphocytes, Plasmablast and Transitional B…

Primary: Overall Mean Sensor Glucose by Age Group — 98; 103; 97; 96 mg/dL — p=0.009

Primary: Mean Change in Sensor Glucose in Subjects With Type 1 Diabetes — -26.4; 12.0 mg/dL

Primary: Percentage of Time Spent With Dexcom CGMG < 60 mg/dl — 1.32; 1.95; 1.05; 0.99 percentage of time

Primary: [11C]5-hydroxy-tryptophan Uptake in the Pancreas — 0.17; 0.21; 0.20; 0.23 % of injected dose — p=0.5875

Primary: Insulin Sensitivity — 3.37*10^-4 1/min per uU/mL

Primary: Performance: EEG Recordings - Impedance — 2.3 Impedance (kOhm)

Primary: Rate of Type 1 Diabetes Per Year Among Individuals in the Primary Stratum When Treated With Oral Inulin Versus Placebo — 0.088; 0.102 Proportion with diabetes/year

Primary: Primary Safety Outcome — 1.4 Percentage of all glucose values

Primary: Change in Glucose Levels Between Pre-treatment and End of Treatment as Measured by 24-hour Continuous Glucose Monitoring (CGM) — -4.94; -10.00; -1.21; -11.42 mg/dL…

Primary: Mean VMAT2 Functional Binding Capacity in the β Cells to 18 F-FP-DTBZ — 103; 38 unitless

Primary: Daily Average Blood Glucose (Avg. BG) at Week 8 Endpoint as Measured by the 8-Point Self-Monitored Blood Glucose (SMBG) Profiles — 7.98; 8.53 millimole per Liter…

Primary: Energy Expenditure — 1978.3; 1969.8; 2414.8; 1497.7 Kilocalories — p=0.24

Primary: Insulin Sensitivity — 8.6; 6.2; 5.8; 4.8 mg/kg/min

Primary: Hypoglycemic Events — 0.27; 1.0; 0.18; 0.18 events/patient

Primary: The Change in Plasma Glucagon Levels (Pmol/L) Measured During Normoglycaemic and Hypoglycaemia — 1.34; 1.68; 2.26; 0.31 pmol/L — p=>0.99

Primary: Insulin Sensitivity — 0.1; 0.07 mL/kg/min per uU/mL

Primary: Hypoglycemic Events — 1.08; 0.4; 1.4; 1.6 events/admission per patient

Primary: Mean Postprandial Glucose — 9.2 mmol/l

Primary: Percent of Time Spent Near Normoglycemia — 43.4; 18.9; 45.1; 21.3 percentage time near normoglycemia

Primary: Mean Energy Expenditure Between HIIT and MICT — 264.5; 225.5 kcal — p=0.010

Primary: Mean Dexcom CGM Glucose (CGMG) Level — 152.8; 137.1 mg/dl

Primary: Measurement of the Effectiveness of APD and FMPD/APD Intervention in Adapting to Reduced Insulin Sensitivity — 176; 195 mg/dl

Primary: Percent of All Glucose Values Within Glucose Range < 70 mg/dL — 0 Percentage of all glucose values

Primary: Change Between Pre and Post Challenge Glucose Variability — 0.51; 1.62; 3.71; 0.97 score on a scale

Primary: Change in GAD65 Autoantibody Titer (DK Units/mL) — 247; 234; 193; 196 DK Units/mL

Primary: Change in Glycated Hemoglobin (HbA1c) From Baseline to 26 Weeks in the Continuous Glucose Monitoring (CGM) and Control Groups (for the Cohort With Baseline HbA1c >=7.0%…

Primary: Change in C-peptide Area Under the Curve Measured by Mixed-meal Tolerance Test (MMTT) Between Group on GFD and Standard Gluten-containing Diet. — 1539; 1173 pmol*min/l…

Primary: Glutathione Concentration — 706; 734 umol/L

Primary: Hyperglycaemia Avoidance Scale — 44.6 score on a scale